Finance

Lists
Why is RLMD up 6,94%?
Dive Deeper
RLMD:NASDAQ
Relmada Therapeutics Inc
3,39 $
+6,94%
(+0,22) 1D
3,39 $
0,00% (0,00)
After hours
Closed: 9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RLMD...
Open
3,18 $
High
3,54 $
Low
3,16 $
Mkt. cap
361,61 մլն
Avg. vol.
1,27 մլն
Volume
1,73 մլն
52-wk high
8,00 $
52-wk low
1,80 $
EPS
-0,96 $
Beta
0,51
Shares outstanding
106,67 մլն
No. of employees
17
Open
3,18 $
High
3,54 $
Low
3,16 $
Mkt. cap
361,61 մլն
Avg. vol.
1,27 մլն
Volume
1,73 մլն
52-wk high
8,00 $
52-wk low
1,80 $
EPS
-0,96 $
Beta
0,51
Shares outstanding
106,67 մլն
No. of employees
17
News stories
From web sources and news partners
About Relmada Therapeutics Inc
CEO-
Employees17
Founded2004
HeadquartersՔորալ Գեյբլս, Ֆլորիդա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to RLMD in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RLMD in the last 3 months.
Highest
Current 3,39 $
12,00 $ (+253,98%)
Average
12,00 $ (+253,98%)
Lowest
12,00 $ (+253,98%)
Analyst
Recommendation
Action
Price target
Projected
Date
Uy Ear
Mizuho Securities
Buy
Reiterated
19,00 $
+460,5%
08/11/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
12,00 $
+254%
08/10/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
12,00 $
+254%
08/07/2026
Christopher Liu
Lucid Capital
Buy
Initiated
14,00 $
+313%
03/02/2026
Last report
10 նոյ, 2022 թ.
Fiscal period
Q3 2022
-1,26 $ / -1,47 $
+14,22%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q3 2022 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,04 մլն
5,17 մլն
8,09 մլն
8,39 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,29 մլն
12,26 մլն
11,37 մլն
6,62 մլն
Operating expense
10,33 մլն
17,43 մլն
19,46 մլն
15,01 մլն
Total operating expenses
10,33 մլն
17,43 մլն
19,46 մլն
15,01 մլն
Operating income
-10,33 մլն
-17,43 մլն
-19,46 մլն
-15,01 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-10,09 մլն
-19,87 մլն
-19,05 մլն
-12,91 մլն
EBT excluding unusual items
-10,08 մլն
-17,05 մլն
-18,50 մլն
-12,71 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10,09 մլն
-19,87 մլն
-19,05 մլն
-12,91 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
247,01 հզր
387,23 հզր
959,76 հզր
2,30 մլն
Interest expense
-
-
-
-
Net interest expenses
247,01 հզր
387,23 հզր
959,76 հզր
2,30 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps